Health Condition 1: K069- Disorder of gingiva and edentulousalveolar ridge, unspecified Health Condition 2: D683- Hemorrhagic disorder due to circulating anticoagulants
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: Patients belonging to ASA Grade I - III Patients on antithrombotic therapy requiring dental implant procedure Patients requiring 1-5 dental Implants Patients willing to participate in the study with informed written consent having obtained medical fitness from the physician
Exclusion criteria
Exclusion criteria: Patients with recent history of myocardial infract, bypass surgery of heart within six months Patients having INR (International normalized ratio) more than 3 Patients below age 18 Pregnant or lactating women Patients not abiding to the study protocol
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Feracrylum is effective as a local hemostatic, antiseptic and hygroscopic agent in patients on antithrombotic therapy undergoing dental implant procedureTimepoint: 2 minute 5 minute 30 minute 24 hours 7th day | — |
Secondary
| Measure | Time frame |
|---|---|
| NILTimepoint: NIL | — |
Countries
India
Contacts
Swargiya Dadasaheb Kalmegh Smruti Dental College and Hospital